Sector Gamma AS’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
JT
Sector Gamma AS's PTCT Position: Q2 2026 in Review
Sector Gamma AS increased its PTC Therapeutics (PTCT) stake by 33% in Q2 2026, buying an estimated $1.81M and bringing the position to 100,000 shares worth $8.16M. The position accounts for 1.77% of the portfolio, ranked #25.
Sector Gamma AS first reported a position in PTCT in Q1 2019 and has held it in 19 quarters since. The position peaked at $10.3M in Q2 2019. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Sector Gamma AS held 100,000 shares of PTC Therapeutics worth $8.16M as of Q2 2026.
- Sector Gamma AS bought 25,000 PTC Therapeutics shares in Q2 2026, an estimated $1.81M.
- PTC Therapeutics made up 1.77% of Sector Gamma AS's portfolio in Q2 2026, its #25 holding.
- Sector Gamma AS first reported a position in PTC Therapeutics in Q1 2019 and has held it in 19 quarters since.
- Sector Gamma AS's PTC Therapeutics position peaked at $10.3M in Q2 2019.
- 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.